Correction: TPL inhibits the invasion and migration of drug-resistant ovarian cancer by targeting the PI3K/AKT/NF-κB-signaling pathway to inhibit the polarization of M2 TAMs - Le, Fuyin; Yang, Lilan; Han, Yiwen; Zhong, Yanying; Zhan, Fuliang; Feng, Ying; Hu, Hui; Chen, Tingtao; Tan, Buzhen (Frontiers in Oncology, 2025)